India Approves AstraZeneca Covid-19 Vaccine

Covid-19 vaccine
In this July 18, 2020 AP file photo a general view of AstraZeneca offices and the corporate logo in Cambridge, England. AstraZeneca says late-stage trials of its COVID-19 vaccine were "highly effective'' in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday November 23, 2020. Photo: AP

An expert panel of the Indian government has approved the urgent use of the novel Coronavirus vaccine made by Oxford University in the UK and Swedish-British multinational pharmaceutical company AstraZeneca.

Experts from the Central Drug Standards Control Organization of India approved the vaccine at a meeting in Oxford on Friday, Reuters reports citing two sources who are aware of the issue.

India wants to start a vaccine program soon, a source, who spoke on condition of anonymity, told Reuters, likely on Wednesday.

A representative of the Central Drug Standard Control Organization of India did not comment when asked about this, the report said.

The UK approved the use of the Oxford-AstraZeneca Coronavirus vaccine on December 30 as the first country in the world. The vaccine was later approved in Argentina.

Apart from the Oxford vaccine, the experts are considering the urgent use of the vaccine made by American pharmaceutical company Pfizer and German biotech company BioNTech.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here